The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism

類似資料

• MK-801 inhibits L-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism
  著者:: Paquette, Melanie A., 等
  出版事項: (2010)
• The effects of BMY-14802 against L-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian rat
  著者:: Bhide, Nirmal, 等
  出版事項: (2013)
• Sigma ligands, but not N-methyl-d-aspartate antagonists, reduce levodopa-induced dyskinesias
  著者:: Paquette, Melanie A., 等
  出版事項: (2008)
• Evaluation of the D3 Dopamine Receptor Selective Antagonist PG01037 on L-Dopa Dependent Abnormal Involuntary Movements in Rats
  著者:: Kumar, Rakesh, 等
  出版事項: (2009)
• Palmitoyl Serotonin Inhibits L-dopa-induced Abnormal Involuntary Movements in the Mouse Parkinson Model
  著者:: Park, Hye-Yeon, 等
  出版事項: (2016)